SCHEMBL3875014

SCHEMBL3875014

CCCc1cc2c(O)c(c1)Cc1cc(CCC)cc(c1O)Cc1cc(CCC)cc(c1O)Cc1cc(CCC)cc(c1O)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 3/20 0.48
PTPN2 P17706 3/20 0.43
PTPN1 P18031 3/20 0.43
PTPN11 Q06124 3/20 0.43
PTPN4 P29074 1/20 0.43
PTPN9 P43378 1/20 0.43
CNR1 P21554 3/20 0.42
CNR2 P34972 3/20 0.42
PTGS2 P35354 3/20 0.39
CYP3A4 P08684 1/20 0.39
ING2 Q9H160 1/20 0.39
HTT P42858 2/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
DUSP5 Q16690 1/20 0.36
DUSP6 Q16828 1/20 0.36
LPL P06858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3877397 0.87 PTPRB (0.40) PTPRBPTPN2PTPN1PTPN11PTPN4
SCHEMBL1173905 0.73 HTT (0.52) CNR1CNR2PTGS2CYP3A4HTT
SCHEMBL1473025 0.72 PTPRB (0.37) PTPRBPTPN2PTPN1PTPN11PTPN4
SCHEMBL542181 0.71 PTGS2 (0.55) CNR1CNR2PTGS2CYP3A4HTT
SCHEMBL12514479 0.71 TTR (0.48) CNR1CNR2PTGS2CYP3A4HTT
SCHEMBL1023215 0.71 DHFR (0.45) PTPN1PTPN11CNR1CNR2PTGS2
SCHEMBL18538254 0.71 PTPN2 (0.50) PTPRBPTPN2PTPN1PTPN11PTPN4
SCHEMBL4900256 0.71 CNR1 (0.50) CNR1CNR2NPC1MAPK1RAB9A
Ammonia Solution, Strong SCHEMBL2441862 0.71 CNR1 (0.45) CNR1CNR2LPLLIPGALOX5
SCHEMBL7700304 0.71 CNR1 (0.46) CNR1CNR2PTGS2CYP3A4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585928-B2 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices DOW GLOBAL TECHNOLOGIES (US) 2009-09-08 US disclosed
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES LLC 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom LRBA, CD74, BMP2 PTPRB 600/4885PTPN2 3245/4885PTPN1 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.